Edwin Rock, Chief Medical Officer at GLYCOMIMETICS INC (GLYC), bought 200,000 shares at $1.43 ($309K) on 2022-11-14, disclosed to the SEC on 2022-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.43 | 100,000 | $143K | 46.3% |
| 2 | $1.66 | 100,000 | $166K | 53.7% |
| Total | $1.54 avg | 200,000 | $309K | 100% |
| Filing → |
| GLYC | BUY | 2022-12-27 | $248K | — | Filing → |